摘要
中国医药行业面临着带量采购、医保控费等医改政策,传统盈利模式暴露的成本高和灵敏性差等问题亟待解决。在此背景下,轻资产盈利模式逐渐成为应对行业变革的有效途径,技术创新也成为医疗企业转型发展的重要驱动力。文章聚焦于价值链视角下,探讨医药行业如何通过轻资产模式实现盈利模式优化,分析价值链在轻资产转型中的衔接与协同作用,并提出相应的优化路径,为医药行业企业提供理论指引与实践借鉴,助力医药企业提高经济效益与市场竞争力。
China's pharmaceutical industry is facing the reform of medical reform policies such as volume-based procurement and medical insurance fee control.The problems of high cost and poor sensitivity exposed by the traditional profit model need to be solved urgently.In this context,the light-asset profit model has gradually become an effective way to deal with industry changes,and technological innovation has also become an important driving force for the transformation and development of medical enterprises.This paper focuses on the perspective of value chain,discusses how the pharmaceutical industry can optimize the profit model through the light-asset model,and proposes the corresponding optimization paths by analyzing the convergence and synergy of the value chain in the light-asset transformation.It provides theoretical guidance and practical reference for pharmaceutical industry and enterprises,and helps them improve economic efficiency and market competitiveness.
作者
王涵
WANG Han(Hebei University of Engineering,Handan 056000,China)
出处
《商业观察》
2026年第8期66-68,共3页
BUSINESS OBSERVATION
关键词
价值链
医药行业
轻资产
盈利模式
value chain
pharmaceutical industry
light-asset
profit model
